Zillow Group Inc (Symbol: Z) has seen its shares rise above the average 12-month analyst target price of $82.23, currently trading at $84.16 per share. When a stock surpasses an analyst’s target, they face two choices: downgrade the stock’s valuation or raise their target price. This response often hinges on the company’s underlying performance; positive developments might prompt an upward revision of the target.
A total of 22 analysts within the Zacks coverage universe contribute to Zillow’s average target. However, this average reflects a range of opinions. Notably, some analysts have set targets below the average, with one predicting a price of $50.00, while another suggests a high of $110.00. The standard deviation in these targets stands at $13.763, indicating varied expectations among analysts.
The purpose of referencing the average target price is to leverage collective insights from multiple analysts, rather than relying on a single viewpoint. As Zillow’s stock trades above the $82.23 mark, investors are prompted to reevaluate their positions: Is this merely a step toward higher valuations, or has the stock become overvalued enough to consider selling? The following table illustrates the current sentiment among analysts covering Zillow Group Inc:
| Recent Z Analyst Ratings Breakdown | ||||
|---|---|---|---|---|
| » | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
| Strong buy ratings: | 13 | 13 | 13 | 13 |
| Buy ratings: | 1 | 1 | 1 | 1 |
| Hold ratings: | 10 | 10 | 10 | 10 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 1 | 1 | 1 | 1 |
| Average rating: | 2.0 | 2.0 | 2.0 | 2.0 |
The average rating, represented on a scale of 1 to 5 (1 being Strong Buy and 5 being Strong Sell), reflects a consensus among analysts. This article incorporates data from Zacks Investment Research via Quandl.com. For more insights, consider reviewing the latest Zacks research report on Z — available at no cost.
10 ETFs With Most Upside To Analyst Targets »
Additional Resources:
QQQC Options Chain
Institutional Holders of BIOF
MXCT shares outstanding history
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
